{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T05:23:03Z","timestamp":1783488183801,"version":"3.55.0"},"reference-count":32,"publisher":"American Medical Association (AMA)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"<jats:sec id=\"ab-zoi250075-4\"><jats:title>Importance<\/jats:title><jats:p>The widespread use of glucocorticoid (GC) therapy may result in GC-induced adrenal insufficiency (GIAI), but the prevalence and clinical implications remain uncertain.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi250075-5\"><jats:title>Objective<\/jats:title><jats:p>To ascertain the prevalence and symptoms of GIAI.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi250075-6\"><jats:title>Design, Setting, and Participants<\/jats:title><jats:p>Cross-sectional multicenter study at 3 Danish hospitals. Baseline data were collected March 2021 to March 2024 from an ongoing randomized clinical trial. Participants were patients with polymyalgia rheumatica and\/or giant cell arteritis who were investigated a median (IQR) of 39 (25-62) days after planned cessation of prednisolone treatment.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi250075-7\"><jats:title>Exposure<\/jats:title><jats:p>Prednisolone treatment a median (IQR) of 13 (10-20) months in duration.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi250075-8\"><jats:title>Main outcomes and measures<\/jats:title><jats:p>Primary outcome GIAI was defined as a stimulated plasma cortisol level less than 420 nmol\/L in response to a short 250 \u03bcg corticotropin test (SST). Secondary outcomes were adrenal insufficiency symptoms assessed by the Addison disease-specific quality of life questionnaire (AddiQoL-30), body composition, and muscle function.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi250075-9\"><jats:title>Results<\/jats:title><jats:p>Of 267 patients included (145 female [55%]; median [IQR] age 73 [68-78] years), 5 (1.9%; 95% CI, 0.8%-4.3%) had GIAI, whereas 75 (34%; 95% CI, 28%-41%) had symptoms compatible with adrenal insufficiency defined by an AddiQoL-30 score 85 or lower (symptomatic group). The symptomatic group had lower basal cortisol levels compared with the asymptomatic group (263 nmol\/L; 95% CI, 242-283 nmol\/L vs 309 nmol\/L; 95% CI, 295-324 nmol\/L; <jats:italic>P<\/jats:italic>\u2009&amp;amp;lt;\u2009.001). Factors associated with a low AddiQoL-30 score included female sex (prevalence ratio [PR], 1.68; 95% CI, 1.13-2.51), increased body fat percentage (PR, 2.33; 95% CI, 1.21-4.50), reduced handgrip strength (PR, 2.71; 95% CI, 1.44-5.10) and low Short Physical Performance Battery score (PR, 2.78; 95% CI, 1.42-5.42).<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi250075-10\"><jats:title>Conclusions and Relevance<\/jats:title><jats:p>This cross-sectional study of 267 patients with polymyalgia rheumatica or giant cell arteritis found a GIAI prevalence of 1.9% after cessation of prednisolone. This is much lower than previously reported and speaks against routine screening, which should be restricted to patients with overt symptoms. The high prevalence of symptoms of adrenal insufficiency in association with lower basal cortisol levels substantiate the clinical challenges of steroid withdrawal and merit future research.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2025.1029","type":"journal-article","created":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T15:00:42Z","timestamp":1742310042000},"page":"e251029","source":"Crossref","is-referenced-by-count":11,"title":["Changes in Adrenal Function and Insufficiency Symptoms After Cessation of Prednisolone"],"prefix":"10.1001","volume":"8","author":[{"given":"Simon B\u00f8ggild","family":"Hansen","sequence":"first","affiliation":[{"name":"Aarhus University Hospital, Department of Endocrinology and Internal Medicine, Aarhus, Denmark"},{"name":"Aarhus University, Department of Clinical Medicine, Aarhus, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja Fenger","family":"Dreyer","sequence":"additional","affiliation":[{"name":"Odense University Hospital, Department of Endocrinology, Odense, Denmark,"},{"name":"University of Southern Denmark, Research Unit OPEN, Department of Clinical Research, Odense, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nanna Thurmann","family":"J\u00f8rgensen","sequence":"additional","affiliation":[{"name":"University of Copenhagen, Department of Clinical Medicine, Faculty of Health and Clinical Sciences, Copenhagen, Denmark"},{"name":"Copenhagen University Hospital, Rigshospitalet, Department of Nephrology and Endocrinology, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hajir","family":"Al-Jorani","sequence":"additional","affiliation":[{"name":"Odense University Hospital, Department of Endocrinology, Odense, Denmark,"},{"name":"University of Southern Denmark, Research Unit OPEN, Department of Clinical Research, Odense, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lise Sofie","family":"Bislev","sequence":"additional","affiliation":[{"name":"Aarhus University Hospital, Department of Endocrinology and Internal Medicine, Aarhus, Denmark"},{"name":"Aarhus University, Department of Clinical Medicine, Aarhus, Denmark"},{"name":"Randers Hospital, Department of Internal Medicine, Randers, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor Brun","family":"Boesen","sequence":"additional","affiliation":[{"name":"Copenhagen University Hospital, Rigshospitalet, Department of Nephrology and Endocrinology, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stina Willemoes","family":"Borresen","sequence":"additional","affiliation":[{"name":"Copenhagen University Hospital, Rigshospitalet, Department of Nephrology and Endocrinology, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise Lehmann","family":"Christensen","sequence":"additional","affiliation":[{"name":"Odense University Hospital, Department of Endocrinology, Odense, Denmark,"},{"name":"University of Southern Denmark, Research Unit OPEN, Department of Clinical Research, Odense, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorte","family":"Glintborg","sequence":"additional","affiliation":[{"name":"Odense University Hospital, Department of Endocrinology, Odense, Denmark,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen Margrethe","family":"Hauge","sequence":"additional","affiliation":[{"name":"Aarhus University, Department of Clinical Medicine, Aarhus, Denmark"},{"name":"Aarhus University Hospital, Department of Rheumatology, Aarhus, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merete Lund","family":"Hetland","sequence":"additional","affiliation":[{"name":"University of Copenhagen, Department of Clinical Medicine, Faculty of Health and Clinical Sciences, Copenhagen, Denmark"},{"name":"Copenhagen Center for Arthritis Research (COPECARE), Center for Rheumatology and Spine Diseases, Centre for Head and Orthopaedics, Rigshospitalet, Glostrup, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard Christian","family":"Jensen","sequence":"additional","affiliation":[{"name":"Odense University Hospital, Department of Endocrinology, Odense, Denmark,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00f8ren Andreas","family":"Just","sequence":"additional","affiliation":[{"name":"Svendborg Hospital\u2013Odense University Hospital, Department of Medicine, Section of Rheumatology, Svendborg, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kresten Krarup","family":"Keller","sequence":"additional","affiliation":[{"name":"Aarhus University, Department of Clinical Medicine, Aarhus, Denmark"},{"name":"Aarhus University Hospital, Department of Rheumatology, Aarhus, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne","family":"Klose","sequence":"additional","affiliation":[{"name":"Copenhagen University Hospital, Rigshospitalet, Department of Nephrology and Endocrinology, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Laugesen","sequence":"additional","affiliation":[{"name":"Aarhus University Hospital, Department of Clinical Epidemiology, Aarhus, Denmark"},{"name":"Aarhus University Hospital, Department of Clinical Biochemistry, Aarhus, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henning","family":"Locht","sequence":"additional","affiliation":[{"name":"Copenhagen Center for Arthritis Research (COPECARE), Center for Rheumatology and Spine Diseases, Centre for Head and Orthopaedics, Rigshospitalet, Glostrup, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie Louise","family":"Lund","sequence":"additional","affiliation":[{"name":"Copenhagen University Hospital, Rigshospitalet, Department of Nephrology and Endocrinology, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jelena","family":"Stankovic","sequence":"additional","affiliation":[{"name":"Aarhus University Hospital, Department of Endocrinology and Internal Medicine, Aarhus, Denmark"},{"name":"Aarhus University, Department of Clinical Medicine, Aarhus, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul M.","family":"Stewart","sequence":"additional","affiliation":[{"name":"University of Leeds, Faculty of Medicine and Health, Leeds, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randi Maria Hangh\u00f8j","family":"Tei","sequence":"additional","affiliation":[{"name":"Aarhus University Hospital, Department of Endocrinology and Internal Medicine, Aarhus, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Voss","sequence":"additional","affiliation":[{"name":"Odense University Hospital, Department of Rheumatology, Odense, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulla","family":"Feldt-Rasmussen","sequence":"additional","affiliation":[{"name":"University of Copenhagen, Department of Clinical Medicine, Faculty of Health and Clinical Sciences, Copenhagen, Denmark"},{"name":"Copenhagen University Hospital, Rigshospitalet, Department of Nephrology and Endocrinology, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens Otto L.","family":"J\u00f8rgensen","sequence":"additional","affiliation":[{"name":"Aarhus University Hospital, Department of Endocrinology and Internal Medicine, Aarhus, Denmark"},{"name":"Aarhus University, Department of Clinical Medicine, Aarhus, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne Skovsager","family":"Andersen","sequence":"additional","affiliation":[{"name":"Odense University Hospital, Department of Endocrinology, Odense, Denmark,"},{"name":"University of Southern Denmark, Research Unit OPEN, Department of Clinical Research, Odense, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2025,3,18]]},"reference":[{"issue":"12","key":"zoi250075r1","doi-asserted-by":"publisher","first-page":"4849","DOI":"10.1210\/jc.2006-0076","article-title":"Premature mortality in patients with Addison\u2019s disease: a population-based study.","volume":"91","author":"Bergthorsdottir","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"5362","key":"zoi250075r2","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1136\/bmj.2.5362.887","article-title":"Eighty-six cases of Addison\u2019s disease.","volume":"2","author":"Dunlop","year":"1963","journal-title":"BMJ"},{"issue":"6","key":"zoi250075r3","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1210\/jc.2012-3582","article-title":"Multisystem morbidity and mortality in Cushing\u2019s syndrome: a cohort study.","volume":"98","author":"Dekkers","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"zoi250075r4","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/S2213-8587(14)70142-1","article-title":"Diagnosis and management of adrenal insufficiency.","volume":"3","author":"Bancos","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"9996","key":"zoi250075r5","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/S0140-6736(14)61375-1","article-title":"Cushing\u2019s syndrome.","volume":"386","author":"Lacroix","year":"2015","journal-title":"Lancet"},{"issue":"3","key":"zoi250075r6","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1530\/EJE-19-0305","article-title":"Fifteen-year nationwide trends in systemic glucocorticoid drug use in Denmark.","volume":"181","author":"Laugesen","year":"2019","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"zoi250075r7","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1093\/qjmed\/93.2.105","article-title":"Use of oral corticosteroids in the United Kingdom.","volume":"93","author":"van Staa","year":"2000","journal-title":"QJM"},{"issue":"5","key":"zoi250075r8","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1007\/s40265-014-0202-z","article-title":"Meta-review: adverse effects of inhaled corticosteroids relevant to older patients.","volume":"74","author":"Mattishent","year":"2014","journal-title":"Drugs"},{"issue":"9","key":"zoi250075r9","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1001\/jamainternmed.2013.122","article-title":"Use of glucocorticoids and risk of venous thromboembolism: a nationwide population-based case-control study.","volume":"173","author":"Johannesdottir","year":"2013","journal-title":"JAMA Intern Med"},{"issue":"6","key":"zoi250075r10","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1210\/jc.2015-1218","article-title":"Adrenal insufficiency in corticosteroids use: systematic review and meta-analysis.","volume":"100","author":"Broersen","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"zoi250075r11","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1530\/EJE-17-0251","article-title":"Adrenal insufficiency is seen in more than one-third of patients during ongoing low-dose prednisolone treatment for rheumatoid arthritis.","volume":"177","author":"Borresen","year":"2017","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"zoi250075r12","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/S2213-2600(21)00352-0","article-title":"Oral corticosteroid elimination via a personalised reduction algorithm in adults with severe, eosinophilic asthma treated with benralizumab (PONENTE): a multicentre, open-label, single-arm study.","volume":"10","author":"Menzies-Gow","year":"2022","journal-title":"Lancet Respir Med"},{"issue":"4","key":"zoi250075r13","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1210\/jc.2017-02602","article-title":"The short cosyntropin test revisited: new normal reference range using LC-MS\/MS.","volume":"103","author":"Ueland","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"zoi250075r14","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.jpainsymman.2006.08.013","article-title":"The steroid withdrawal syndrome: a review of the implications, etiology, and treatments.","volume":"33","author":"Margolin","year":"2007","journal-title":"J Pain Symptom Manage"},{"issue":"9","key":"zoi250075r15","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1210\/jcem-25-9-1207","article-title":"Certain endocrine and metabolic facets of the steroid withdrawal syndrome.","volume":"25","author":"Amatruda","year":"1965","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"zoi250075r16","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1210\/er.2001-0014","article-title":"Endocrine withdrawal syndromes.","volume":"24","author":"Hochberg","year":"2003","journal-title":"Endocr Rev"},{"issue":"3","key":"zoi250075r17","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/rheumatology\/kez672","article-title":"British Society for Rheumatology guideline on diagnosis and treatment of giant cell arteritis.","volume":"59","author":"Mackie","year":"2020","journal-title":"Rheumatology (Oxford)"},{"issue":"10","key":"zoi250075r18","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1136\/annrheumdis-2015-207492","article-title":"2015 Recommendations for the management of polymyalgia rheumatica: a European League Against Rheumatism\/American College of Rheumatology collaborative initiative.","volume":"74","author":"Dejaco","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"zoi250075r19","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1515\/cclm-2016-0400","article-title":"Multicenter performance evaluation of a second generation cortisol assay.","volume":"55","author":"Vogeser","year":"2017","journal-title":"Clin Chem Lab Med"},{"issue":"2","key":"zoi250075r20","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1210\/jc.2011-1901","article-title":"Quality of life in European patients with Addison\u2019s disease: validity of the disease-specific questionnaire AddiQoL.","volume":"97","author":"\u00d8ksnes","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"zoi250075r21","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1530\/EJE-07-0762","article-title":"Evaluation of health-related quality of life in patients with Cushing\u2019s syndrome with a new questionnaire.","volume":"158","author":"Webb","year":"2008","journal-title":"Eur J Endocrinol"},{"issue":"11","key":"zoi250075r22","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.5664\/jcsm.7478","article-title":"A new single-item sleep quality scale: results of psychometric evaluation in patients with chronic primary insomnia and depression.","volume":"14","author":"Snyder","year":"2018","journal-title":"J Clin Sleep Med"},{"issue":"6","key":"zoi250075r23","article-title":"Interventions for reducing sedentary behaviour in community-dwelling older adults.","volume":"6","author":"Chastin","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"zoi250075r24","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.semarthrit.2016.03.001","article-title":"Systemic glucocorticoid therapy and adrenal insufficiency in adults: a systematic review.","volume":"46","author":"Joseph","year":"2016","journal-title":"Semin Arthritis Rheum"},{"issue":"4","key":"zoi250075r25","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1210\/jc.2006-1791","article-title":"Factors influencing the adrenocorticotropin test: role of contemporary cortisol assays, body composition, and oral contraceptive agents.","volume":"92","author":"Klose","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"zoi250075r26","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s12020-024-03752-0","article-title":"Determination of cortisol cut-off limits and steroid dynamics in the ACTH stimulation test: a comparative analysis using Roche Elecsys Cortisol II immunoassay and LC-MS\/MS.","volume":"85","author":"Okutan","year":"2024","journal-title":"Endocrine"},{"issue":"11","key":"zoi250075r27","doi-asserted-by":"publisher","first-page":"e2031","DOI":"10.1210\/clinem\/dgae059","article-title":"A retrospective study on weaning glucocorticoids and recovery of the hypothalamic-pituitary-adrenal axis.","volume":"109","author":"Arshad","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"zoi250075r28","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1210\/clinem\/dgae250","article-title":"European Society of Endocrinology and Endocrine Society joint clinical guideline: diagnosis and therapy of glucocorticoid-induced adrenal insufficiency.","volume":"109","author":"Beuschlein","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"zoi250075r29","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1210\/er.2018-00097","article-title":"Glucocorticoids and bone: consequences of endogenous and exogenous excess and replacement therapy.","volume":"39","author":"Hardy","year":"2018","journal-title":"Endocr Rev"},{"issue":"701","key":"zoi250075r30","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adg8464","article-title":"High-resolution daily profiles of tissue adrenal steroids by portable automated collection.","volume":"15","author":"Upton","year":"2023","journal-title":"Sci Transl Med"},{"issue":"4","key":"zoi250075r31","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1210\/endrev\/bnae008","article-title":"The glucocorticoid receptor: isoforms, functions, and contribution to glucocorticoid sensitivity.","volume":"45","author":"Lockett","year":"2024","journal-title":"Endocr Rev"},{"issue":"5","key":"zoi250075r32","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.1021\/acs.analchem.3c04435","article-title":"Highly Responsive Bioassay for Quantification of Glucocorticoids.","volume":"96","author":"Poulsen","year":"2024","journal-title":"Anal Chem"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2831668\/hansen_2025_oi_250075_1741708855.89403.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T15:00:45Z","timestamp":1742310045000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2831668"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,18]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3,3]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2025.1029","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,18]]}}}